MINI FUTURE LONG - VIRBAC Stock

Certificat

DE000ME2KAN7

Real-time Bid/Ask 08:29:56 2024-05-23 EDT
12.41 EUR / 12.51 EUR -1.81% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+11.41%
1 month-9.16%
Date Price Change
24-05-23 12.52 -1.34%
24-05-22 12.69 +6.91%
24-05-21 11.87 +2.06%
24-05-20 11.63 -3.00%
24-05-17 11.99 -5.96%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 03:40 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN ME2KAN
ISINDE000ME2KAN7
Date issued 2023-10-25
Strike 235.8
Maturity Unlimited
Parity 10 : 1
Emission price 5.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.27
Lowest since issue 4.48
Spread 0.1
Spread %0.80%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
361 EUR
Average target price
372.4 EUR
Spread / Average Target
+3.17%
Consensus